Ola Electric has denied claims that its technology derives from leaked proprietary data from LG Chem. The company emphasized that its Bharat Cell technology employs an advanced dry-electrode process and utilizes a cylindrical cell form factor, which is distinct from LG Energy Solution’s pouch cell technology. Ola indicated that fears of losing market share, particularly with significant customers like Ola Electric, have led foreign competitors to challenge indigenous battery innovations.
Havells India announced through exchanges that it has signed a settlement agreement with the HPL Group and its promoters, resolving all ongoing disputes and litigation concerning the use of the ‘HAVELLS’ mark. This includes cases filed in various courts, such as the Delhi High Court, and special leave petitions in the Supreme Court.
AIK Pipes and Polymers Limited has received a purchase order valued at ₹8.80 crore (approximately) from an AA-Class EPC contracting firm under the Public Health Engineering Department (PHED) of the Government of Rajasthan, for the supply of HDPE pipes for the Isarda Dausa water supply project (Package-4).
Panorama Studios International Ltd has entered into a Distribution Agreement with Golden Bridge Films & Entertainment Private Ltd to exclusively exploit the theatrical rights internationally, including in India, for the Punjabi feature film “Yamla.” The film features actors Rajvir Jawanda and Navneet Dhillon, among others, and is directed by Rakesh Mehta.
Ashoka Buildcon Ltd has received a Letter of Acceptance for a railway upgrade project. The company previously submitted a bid for the project titled “Up-gradation of existing Electric traction system from 1 x 25 kV to 2 x 25 kV along with modification of existing OHE for 160 kmph in select sections of the Ajmer Division of North Western Railway” to the President of India through the CEE/Project/NWR.
Valiant Advanced Sciences Private Limited, a wholly-owned subsidiary of Valiant Laboratories Limited, has commenced commercial operations at its state-of-the-art greenfield manufacturing facility in Saykha GIDC, Bharuch, Gujarat. This facility marks a significant advancement in the company’s backward integration and expansion into the specialty chemicals sector.
Dev Accelerator Ltd has acquired a 35% stake in the equity capital of Eezily Network Private Ltd, which was incorporated on November 6.
The Competition Commission of India (CCI) approved the proposal from Blackstone’s arm to acquire up to an 80.15% stake in Aadhar Housing Finance Ltd. The acquisition will be executed through BCP Asia II Holdco VII Pte Ltd, the investment firm’s subsidiary.
The board of Swiggy has approved raising up to ₹10,000 crore through the Qualified Institutional Placement (QIP) route or other allowed methods to strengthen its growth capital amid a competitive market landscape.
Adani Enterprises Ltd is expected to be the top bidder for the acquisition of Jaiprakash Associates Ltd (JAL) via the insolvency process. This is due to its offer to settle the acquisition amount within two years, outpacing Vedanta’s five-year payment proposal, according to sources. Earlier in September, Vedanta had initially emerged as a leading bidder with an offer of ₹12,505 crore in net present value for JAL, which has diversified interests including real estate, cement, power, and hotels.
The Centre has approved the export of 1.5 million tonnes of sugar for the 2025-26 season starting in October, as reported by Food Minister Pralhad Joshi. Additionally, the Union Food Ministry has decided to eliminate the 50% export duty on molasses, a move communicated during a briefing to Karnataka Chief Minister Siddaramaiah, aimed at safeguarding the interests of sugarcane farmers nationwide.
NBCC (India) Ltd has signed a preliminary agreement with Pantheon Elysee Real Estate Development LLC to collaborate on project development in the UAE. The company announced this broad framework Memorandum of Understanding (MoU) with the Dubai-based real estate company.
Venus Remedies has obtained new marketing authorizations for its drugs Methotrexate, Cefuroxime, and Irinotecan in Vietnam. Methotrexate is an immunosuppressant and anticancer medication; Cefuroxime serves as an antibiotic; while Irinotecan is a chemotherapy agent. These approvals enhance the firm’s export capabilities in South Asia’s burgeoning pharmaceutical market, expanding its portfolio to 29 active product approvals in Vietnam.
In a significant security breach, cyber fraudsters stole ₹2.1 crore from Dr Reddy’s Laboratories by hacking email communications between the company and one of its vendors, diverting the funds to a fraudulent account. Reports indicated that Dr Reddy’s was notified of the scam after the payment was made to impostors posing as a legitimate Bengaluru-based pharmaceutical company. The company subsequently alerted its vendor about the fraud.
Published on November 10, 2025.
